title: The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review.
authors.affiliation: West Midlands Development and Evaluation Service, The University of Birmingham, Birmingham, UK.
authors.forename: A
authors.initials: A
authors.lastname: Stewart
authors.forename: J
authors.initials: J
authors.lastname: Sandercock
authors.forename: S
authors.initials: S
authors.lastname: Bryan
authors.forename: C
authors.initials: C
authors.lastname: Hyde
authors.forename: P M
authors.initials: PM
authors.lastname: Barton
authors.forename: A
authors.initials: A
authors.lastname: Fry-Smith
authors.forename: A
authors.initials: A
authors.lastname: Burls
mesh_terms: D003362:Cost-Benefit Analysis; D006801:Humans; D015994:Incidence; D016472:Motor Neuron Disease / Q000188:drug therapy* / Q000453:epidemiology; D018696:Neuroprotective Agents / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D015995:Prevalence; D016032:Randomized Controlled Trials as Topic; D019782:Riluzole / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D013673:Technology Assessment, Biomedical; D016896:Treatment Outcome; D006113:United Kingdom / Q000453:epidemiology
chemical_list: D018696:Neuroprotective Agents; D019782:Riluzole